Literature DB >> 16083830

Clinical features and diagnosis of primary central nervous system lymphoma.

April Fitzsimmons1, Kristen Upchurch, Tracy Batchelor.   

Abstract

This article reviews the clinical features of primary central nervous system lymphoma (PCNSL) in immunocompetent and immunocompromised patients. Clinical presentation, differential diagnosis, diagnostic testing, and staging evaluation in both immunocompetent and AIDS patients who have PCNSL are discussed. The differing role of biopsy in these two populations also is addressed.

Entities:  

Mesh：

Year:  2005        PMID： 16083830     DOI： 10.1016/j.hoc.2005.05.009

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  9 in total

1.  Cauda equina syndrome due to large B-cell lymphoma: a case report.

Authors:  Vincenzo Belcastro; Silvio Bellcocchi; Carlo Patriarca; Gigliola Gini; Mirko Piola; Salvatore Barca; Marco Arnaboldi
Journal:  Neurol Sci       Date:  2016-01-11       Impact factor: 3.307

Review 2.  Biology and treatment of primary central nervous system lymphoma.

Authors:  Alain P Algazi; Cigall Kadoch; James L Rubenstein
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

3.  Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease.

Authors:  Eugene L Scharf; Curtis A Hanson; Matthew T Howard; B Mark Keegan
Journal:  J Neurooncol       Date:  2016-05-09       Impact factor: 4.130

Review 4.  Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.

Authors:  I S Haldorsen; A Espeland; E-M Larsson
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

5.  MR imaging features of intracranial primary CNS lymphoma in immune competent patients.

Authors:  Asem Mansour; Monther Qandeel; Hikmat Abdel-Razeq; Hussain Ali Abu Ali
Journal:  Cancer Imaging       Date:  2014-05-07       Impact factor: 3.909

6.  Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors.

Authors:  Soley Bayraktar; Ulas D Bayraktar; Juan C Ramos; Alexandra Stefanovic; Izidore S Lossos
Journal:  J Neurooncol       Date:  2010-06-06       Impact factor: 4.506

7.  Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy.

Authors:  Chaoyue Chen; Hongyu Zhuo; Xiawei Wei; Xuelei Ma
Journal:  Contrast Media Mol Imaging       Date:  2019-11-12       Impact factor: 3.161

8.  Autoimmune Hemolytic Anemia preceding the Diagnosis of Primary Central Nervous System Lymphoma.

Authors:  H Farhangi; N Sharifi; H Ahanchian; A Izanloo
Journal:  Iran J Ped Hematol Oncol       Date:  2015-03-15

9.  Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.

Authors:  Defeng Zhao; Liren Qian; Jianliang Shen; Xiaopeng Liu; Ke Mei; Jian Cen; Yaming Wang; Congyong Li; Yuanyuan Ma
Journal:  J Cell Mol Med       Date:  2014-03-13       Impact factor: 5.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.